Panacea Life Sciences Holdings, Inc.
PLSH- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001552189
No open-market purchases or sales by Panacea Life Sciences Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Panacea Life Sciences Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Panacea Life Sciences Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Buttorff Leslie | CEO | 1,533,949 | Sep 20, 2023 | 0 |
| Wert Lawrence | Director | 1,322,868 | Aug 15, 2022 | 0 |
| Berman Nathan Joel | CONTROLLER & PRIN ACTNG OFCR | 496,957 | Jul 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 (view filing)12:21 PM ET | Sep 18 | 2 days | Buttorff LeslieCEO | PPurchase | +20.0K | $0.2365 | +$4.73K | +1.3%1.53M after | |
| Jun 12, 2023 (view filing)4:37 PM ET | Jun 9 | 3 days | Buttorff LeslieCEO | PPurchase | +3.00K | $0.4325 | +$1.30K | +0.2%1.51M after | |
| May 23, 2023 (view filing) | May 19-23 | 4 days | Buttorff LeslieCEO | PPurchase | +6.50K | $0.5115 | +$3.33K | +0.9%751.4K after | 3 lots |
| May 9, 2023 (view filing)7:11 PM ET | May 5-9 | 4 days | Buttorff LeslieCEO | PPurchase | +15.3K | $0.4671 | +$7.15K | +2.1%741.9K after | 3 lots |
| Apr 26, 2023 (view filing)7:38 PM ET | Apr 25-26 | 1 day | Buttorff LeslieCEO | PPurchase | +10.0K | $0.3838 | +$3.84K | +1.4%726.6K after | 3 lots |
| Apr 6, 2023 (view filing)8:18 PM ET | Apr 3-5 | 3 daysLate | Buttorff LeslieCEO | PPurchase | +6.70K | $0.344 | +$2.31K | +0.9%716.6K after | 3 lots |
| Mar 1, 2023 (view filing)4:21 PM ET | Feb 26-27 | 3 daysLate | Buttorff LeslieCEO | PPurchase | +4.00K | $0.1813 | +$725 | +0.6%709.9K after | 3 lots |
| Aug 29, 2022 (view filing)4:01 PM ET | Aug 26 | 3 days | Buttorff LeslieCEO | PPurchase | +15.0K | $0.1366 | +$2.05K | +2.3%660.9K after | 3 lots |
| Aug 15, 2022 (view filing)8:30 AM ET | Aug 11 | 4 days | Wert LawrenceDirector | PPurchase | +15.0K | $0.1307 | +$1.96K | +1.1%1.32M after | 3 lots |
| Aug 5, 2022 (view filing)11:17 AM ET | Aug 3-4 | 2 days | Buttorff LeslieCEO | PPurchase | +18.8K | $0.0985 | +$1.85K | +3.0%645.9K after | 9 lots |
| Jul 12, 2022 (view filing)4:05 PM ET | Jul 8-11 | 4 days | Buttorff LeslieCEO | PPurchase | +7.70K | $0.2837 | +$2.18K | +1.2%627.1K after | 5 lots |
| Apr 6, 2022 (view filing)4:08 PM ET | Apr 4-5 | 2 days | Buttorff LeslieCEO | PPurchase | +18.1K | $0.4979 | +$8.99K | +3.0%619.4K after | 5 lots |